Qiagen N.V. (BIT:1QGEN)
39.31
-1.91 (-4.65%)
At close: Jan 19, 2026
Qiagen Market Cap
Qiagen has a market cap or net worth of €9.8 billion as of January 22, 2026. Its market cap has increased by 1.60% in one year.
Market Cap
9.80B
Enterprise Value
10.20B
Revenue
1.76B
Ranking
n/a
PE Ratio
28.37
Stock Price
€39.31
Market Cap Chart
Since June 28, 1996, Qiagen's market cap has increased from 154.92M to 9.80B, an increase of 6,228.20%. That is a compound annual growth rate of 15.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 9.74B | 17.22% |
| Dec 31, 2025 | 8.31B | -13.12% |
| Dec 31, 2024 | 9.56B | 6.63% |
| Dec 29, 2023 | 8.97B | -15.62% |
| Dec 30, 2022 | 10.63B | -4.23% |
| Dec 31, 2021 | 11.10B | 12.93% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Recordati Industria Chimica e Farmaceutica | 9.71B |
| DiaSorin | 4.01B |
| Amplifon | 2.95B |
| EL.En. | 1.12B |
| Philogen | 845.55M |
| Safilo Group | 798.65M |
| Pharmanutra | 613.65M |
| Garofalo Health Care | 484.94M |